Skip to main content
. 2016 Mar 20;14(1):241–249. doi: 10.1111/iwj.12595

Table 1.

Clinical data of patients treated with epidermal graft

No Patient Gender Age Comorbidities Wound aetiology Location of wound Duration of wound (month) Wound size (cm2) Time for 50% reduction of wound size (weeks) Time for 100% reduction of wound size (weeks) Time for donor site healing (days) Pain score during graft harvest VSS of donor site scar
1 SB F 24 Nil Pyogenic granuloma Foot 4 6 Failed Failed 5 1 0
2 HB M 18 Nil Trauma Knee 1 13·5 2 5 5 3 0
3 RK F 85 IHD, CABG, HTN, asthma Venous ulcer Leg 4 6 2 5 7 2 0
4 BL F 93 Dementia, COPD, HTN, CCF Trauma Leg 1 14 1 3 5 1 0
5 JC M 54 Nil Amputation stump wound dehiscence Foot 2 28 2 4 5 2 0
6 LH F 50 SLE (oral steroids) Venous ulcer Ankle 5 8 2 5 7 2 0
7 JZ M 84 R hemicolectomy, postoperative fistula and hernia Abdominal wound dehiscence Abdomen 60 15·8 4 8 5 1 0
8 GM F 62 Bowen's disease, myasthenia gravis (on oral steroids), osteoporosis Trauma Leg 1·5 12 2 6 5 2 0
9 RF M 78 Prostate cancer, myelodysplasia, IHD, PVD, multiple BCC/SCC Wound dehiscence Leg 3 27 Failed Failed 5 1 0
10 NS F 91 Breast cancer, hypertension, smoker, CKD3 Trauma Leg 3·5 3 2 3 5 3 0
11 LR F 64 RA, COPD Trauma Ankle 9 40 Failed Failed 5 0 0
12 AL F 26 Anaemia smoker Burn Leg 0·5 19 1 3 7 1 0
13 DM F 50 Breast ca and chemo, previous DVT on warfarin Dehiscence of LD donor site Back 4 21 4 8 5 3 0
14 JB F 52 Hypertension, gastric banding, abdominoplast, thigh lift Wound dehiscence Thigh 1 28 4 8 7 2 0
15 JM F 76 Cerebral palsy, hypothyroid, osteoporosis SSG donor site Thigh 24 18 2 4 5 2 0
16 OM M 32 Deaf Trauma Foot 2 26 3 6 5 2 0
17 KI M 82 IHD, CABG, HTN, T2DM, RA (on prednisolone + methotrexate), hypercholesterolaemia, CVA, AAA (4·5 cm) Wound dehiscence Leg 2 16 3 6 5 1 0
18 BR M 78 Previous sigmoid cancer, colostomy, necrotizing fasciitis abdomen, CVA SSG donor site Thigh 36 39 2 5 7 2 0
19 HJ F 85 RA VLU Ankle 24 11·25 12 20 7 1 0
20 AL M 86 Arterial leg ulcer Ankle 60 5·25 4 No change 9 2 0
21 IA M 65 PVD diabetes Diabetic foot ulcer Ankle 15 0·9 1 8 7 0 0
22 MW 4 applications M 70 Bowel cancer Wound dehiscence Abdomen 42 123·5 8 Multiple small areas 3 1 0
23 EVD 2 applications F 80 PVD Mixed arterial leg ulcer Leg 60 15·84 Failed failed 7 2 0
24 EO F 72 RA Trauma Leg 24 4·94 Wound bed more active Wound bed more active 7 2 0
25 MM F 77 Diabetes type 1 Wound dehiscence Abdomen 77 45 Failed Failed 5 1 0
26 TS 3 applications M 72 Bowel cancer Wound dehiscence Abdomen 72 22 Multiple small areas Multiple small areas 3 0 0
27 BH F 80 Nil Wound dehiscence Abdomen 14 21·6 Failed Failed 7 0 0
28 PN 2 applications F 66 Systemic sclerosis VLU Leg 72 67·2 Failed Failed 3 0 0
29 BG M 72 Nil VLU Leg 18 4·05 6 No change 3 0 0
30 JI M 85 Diabetes Trauma Leg 21 2·1 4 No change 3 0 0
31 JS M 88 IHD, CABG, HTN Trauma Forearm 0·5 7 3 5 5 2 0
32 SM M 93 IHD, CABG, HTN, AF SSG donor site Leg 3 9 2 3 5 2 0
33 PS M 28 Nil Wound dehiscence Ankle 5 6 2 4 5 1 0
34 LM F 39 GORD Wound dehiscence Arm 4 18 4 6 7 3 0
35 JK F 58 PE/DVT, PCOS, asthma Trauma Pretibial 5 14 4 5 7 2 0

T1DM, type 1 diabetes mellitus; VSS, Vancouver Scar Scale.